DE GREEF RODERICK 4
4 · BIOLIFE SOLUTIONS INC · Filed Nov 13, 2025
Insider Transaction Report
Form 4
DE GREEF RODERICK
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-11-11$26.15/sh−35,417$926,155→ 454,581 total - Sale
Common Stock
2025-11-12$25.88/sh−33,418$864,858→ 421,163 total - Sale
Common Stock
2025-11-13$25.33/sh−31,165$789,409→ 389,998 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.85 to $26.63, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.64 to $26.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.05 to $25.87, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.